Balancing volume resuscitation and ascites management in cirrhosis

Current Opinion in Anaesthesiology
Federico Polli, Luciano Gattinoni

Abstract

Patients with cirrhosis have total extracellular fluid overload but central effective circulating hypovolaemia. The resulting neurohumoral compensatory response favours the accumulation of fluids into the peritoneal cavity (ascites) and may hinder renal perfusion (hepatorenal syndrome). Their deranged systemic haemodynamics (hyperdynamic circulatory syndrome) is characterized by elevated cardiac output with decreased systemic vascular resistance and low blood pressure. Molecular and biological mechanisms determining cirrhosis-induced haemodynamic alterations are progressively being elucidated. The need for a goal-directed assessment of volume resuscitation (especially with volumetric techniques) in patients with cirrhosis is becoming more and more evident. The role of fluid expansion with albumin and the use of splanchnic vasopressors in a variety of cirrhosis-related conditions has recently been investigated. The response to fluid loading in patients with advanced cirrhosis is abnormal, primarily resulting in expansion of their noncentral blood volume compartment. Colloid solutions, in particular albumin, are best used in these patients. Albumin may be effective in preventing the haemodynamic derangements associated with large...Continue Reading

References

May 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A HadengueD Lebrec
Jun 1, 1992·The Journal of Clinical Investigation·A PietrangeloD A Shafritz
Apr 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J MacGilchristJ L Reid
Jul 15, 1990·Annals of Internal Medicine·R W Schrier
Jul 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R MoreauC Sicot
Dec 1, 1989·Gastroenterology·J H HenriksenH Ring-Larsen
Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R W SchrierJ Rodés
May 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D M SimonJ T Galambos
Jan 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P GinésC Rozman
Dec 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S KaratapanisM Jacobs
Sep 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A LucaJ Rodés
Nov 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W H Abelmann
Dec 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A FolloJ Rodés
Aug 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J F PlattM R Lucey
Mar 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J F FleckensteinP J Thuluvath
Jan 1, 1997·Seminars in Liver Disease·B A Runyon
Feb 12, 1998·Journal of Hepatology·T IwaoK Tanikawa
Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M BernardiG Raimondo
Feb 6, 1998·Journal of Clinical Gastroenterology·C de-la-SernaA Garcia Plaza
Jul 24, 1998·BMJ : British Medical Journal·UNKNOWN Cochrane Injuries Group Albumin Reviewers
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P AngeliA Gatta
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F PiscagliaL Bolondi
Nov 7, 1999·Journal of Hepatology·J H HenriksenF Bendtsen
Feb 24, 2001·Journal of Hepatology·J H HenriksenH Ring-Larsen
Mar 20, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·J H HenriksenS Møller
Feb 5, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Reiner Wiest, Roberto J Groszmann
Feb 28, 2002·Journal of Hepatology·Victoria AndreuJoan Rodés

❮ Previous
Next ❯

Citations

Jan 11, 2012·Molecular Aspects of Medicine·Gabriella FanaliPaolo Ascenzi
Oct 28, 2011·Journal of Magnetic Resonance Imaging : JMRI·Karen S LeeIvan Pedrosa
Nov 27, 2015·BMC Gastroenterology·Francesco SalernoMahlon M Wilkes
Aug 16, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Francesca RattiLuca Aldrighetti
Aug 8, 2018·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Philip YangMajid Afshar
Jun 18, 2019·Expert Review of Gastroenterology & Hepatology·Paolo AseniCherisse Berry
Dec 6, 2019·International Journal of Emergency Medicine·G H RameshSheerin Farhath

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Critical Care : the Official Journal of the Critical Care Forum
Matthias JacobMarkus Rehm
Best Practice & Research. Clinical Anaesthesiology
Jean-Louis Vincent
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
P AngeliA Gatta
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Christophe DuvouxDaniel Dhumeaux
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
M GuevaraJ Rodés
© 2021 Meta ULC. All rights reserved